Accordingly albumin infusion has been proposed to reduce the risk of kernicterus in acute phases of hyperbilirubinemia [26] and in hyperbilirubinemic neonates requiring exchange transfusion, but the efficacy of the treatment is controversial [27]. The gene discussed is ALB; the disease is Hyperbilirubinemia.